MiNK Therapeutics stockholders elect directors, approve option exchange, ratify KPMG at 2025 annual meeting

MiNK Therapeutics, Inc.

Jennifer Buell and Ulf Wiinberg elected as Class I directors with 2,337,073 and 2,312,077 votes For, respectively.
Option exchange proposal approved: 2,269,364 For, 97,538 Against, 1,317 Abstain, 424,803 broker non-votes.
Ratification of KPMG LLP as auditor for FY2025: 2,773,188 For, 12,846 Against, 6,988 Abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.